Who we are:

On June 9, 2017, Olon S.p.A., a leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and Generics supplier, announced the acquisition of Ricerca Biosciences’ Chemical Division of the contract research (CRO) and CDMO based in Concord, Ohio, USA. This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry and benefits Ricerca Biosciences' customer base by providing large-scale manufacturing capabilities in Europe.

Olon Ricerca Bioscience is a US-based CRO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution.  Olon Ricerca’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first-time scale-ups and subsequent development of safe, reliable, robust and cost-effective manufacturing processes. For more than 25 years, Olon Ricerca has a record of on-time delivery and quality, providing comprehensive support and problem solving for successful development, scale-up and process-optimized manufacture of pharmaceutical ingredients.

Company Details

Website:
http://www.olonricerca.com 

Location:
Concord, OH 


Biotechnology

Chemicals

Life Sciences

Pharmaceutical

Olon USA

Olon USA's headquarters in Concord, United States

Description

People (1)

Jobs (0)

Other offices